J&J Loses Dutch Stent Trial Against Boston Scientific

Law360, New York (October 14, 2005, 12:00 AM EDT) -- Johnson & Johnson will have to stop selling certain drug-coated stents in the Netherlands after rival medical device maker Boston Scientific prevailed in the latest chapter of the companies’ extensive litigation.

Boston Scientific sued J&J’s Netherlands-based subsidiary Cordis in Dutch court, asserting its patents for a balloon mechanism used to inflate certain stents.

The companies have been litigating over the medical devices for several years, vying for a bigger share of the $6 billion worldwide market for drug-coated stents.

So far, the infringement suits in the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.